Evidence for Metabolomic Phenotypes Based on Analysis of Plasma from the Autism Phenome Project Cohort [IMFAR 2016]
Presented at the International Meeting for Autism Research, May 2016, in Baltimore, Maryland.
Metabolomics can identify predictive and actionable biomarker profiles from a child’s inherited biochemistry as well as the interactions of the gut microbiome with dietary and environmental factors that may contribute to ASD. Identification of metabolic profiles in children with ASD creates an opportunity to develop metabolic based diagnostics that enable early diagnosis and elucidate biochemical changes associated with ASD.
[pardot-form id=”1025″ title=”IMFAR 2016: Evidence for Metabolomic Phenotypes”]